In the News: July 14–21
By Sg2 TeamThis week: Childhood obesity reduced for impoverished children; consumers avoid complicated care; and accelerating digital strategy during COVID-19
- Share
This week: Childhood obesity reduced for impoverished children; consumers avoid complicated care; and accelerating digital strategy during COVID-19
This week: COVID-19 has enhanced virtual health usage; using precision medicine for immunotherapy efficacy; and health care spending sees 18% drop
This week: Virtual health partnership between the UK and the US; compensation to increase training participation for opioid treatment; and service line losses in patient volume
Join Sg2 and Vizient experts for a series of HealthLeaders webinars that focus on post–COVID-19 financial aspects of recovering elective volumes, reshaping your workforce and consumer access to services
This week: Start-up wants to match patients with therapists; ONC tries to standardize SDOH data; and fraud concerns with virtual health usage
This week: Growth in commercial health care costs; urgent care saturation in urban areas; disparities in maternity care outcomes
This week: Supplemental benefit adoption in Medicare Advantage plans, new payment model for SNFs, and strategic partnerships to improve quality and reduce costs.
This week: A new app to help parents of preemies with care coordination, an underutilized Medicare program for diabetic patients, and a new partnership focuses on reducing infant mortality.
This week: Greater patient access comes from leveraging low-acuity care and physician shortage is growing at an alarming rate.
The provision of ongoing care throughout pregnancy has been shown to decrease complications, and several organizations have turned to virtual health technologies to improve access to care for pregnant women.
This week: HDHPs' impact on consumer behaviors; telehealth for chronic condition management; and post-acute care management
This week: CMS continues site-neutral payment cuts in OPPS final rule; online cognitive behavioral therapy's potential to fill behavioral health services gaps; and FDA approves potent new opioid despite opposition.